Effect of Novel Agents on the Risk of Early Death of Newly Diagnosed Symptomatic Multiple Myeloma Patients: A Single Centre Retrospective Analysis

American Journal of Hematology - United States
doi 10.1002/ajh.25320
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

P1.01-44 Outcome of Uncommon EGFR Mutation Positive Newly Diagnosed Advanced NSCLC Patients: A Single-Centre Retrospective Analysis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Retrospective Analysis of Multiple Myeloma Patients in a Tertiary Care Centre of Uttarakhand

International Journal of Medical and Biomedical Studies
2019English

Novel Therapies in Multiple Myeloma for Newly Diagnosed Nontransplant Candidates

Cancer Journal
Cancer ResearchOncology
2009English

Prognostic Nomogram for the Overall Survival of Patients With Newly Diagnosed Multiple Myeloma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

The Impact of ASCT on Patients With Newly Diagnosed Multiple Myeloma Who Receive RVD Induction

Journal of Hematological Malignancies
2013English

Chromosome 1 Abnormalities in Elderly Patients With Newly Diagnosed Multiple Myeloma Treated With Novel Therapies

Haematologica
Hematology
2014English

Daratumumab in Untreated Newly Diagnosed Multiple Myeloma

Therapeutic Advances in Hematology
Hematology
2019English

Quantification of Clonal Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Implications for Redefining High-Risk Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2014English

Treatment Patterns and Clinical Outcomes in High-Risk Newly Diagnosed Multiple Myeloma Patients Carrying the 17p Deletion: An Observational Multi-Center Retrospective Study

American Journal of Hematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy